Skye Bioscience, Inc. Common Stock Cash Flow Reinvestment Rate

Latest as of June 2014: 8.56x

Skye Bioscience, Inc. Common Stock cash flow reinvestment rate. Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Reinvestment Rate of 8.56x as of June 2014, reinvesting $67.83K (capex $67.83K ) from operating cash flow of $7.92K. Explore SKYE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

8.56x
(Capex + Investments) / Operating CF

Total Reinvested

$67.83K
Capex + Investments

Operating Cash Flow

$7.92K
USD

Capital Expenditures

$67.83K
USD

Cash Flow Reinvestment Rate of Skye Bioscience, Inc. Common Stock (2012–2012)

Cash flow reinvestment rate of Skye Bioscience, Inc. Common Stock from 2012 to 2012. Historical reinvestment intensity for Skye Bioscience, Inc. Common Stock across 1 annual periods. Explore Skye Bioscience, Inc. Common Stock (SKYE) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Skye Bioscience, Inc. Common Stock Cash Flow Reinvestment Rate by Year (2012–2012)

Skye Bioscience, Inc. Common Stock cash flow reinvestment rate by year from 2012 to 2012. Year-by-year capital reinvestment analysis for Skye Bioscience, Inc. Common Stock. For the full cash flow conversion analysis, see SKYE operating cash flow.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2012 0.00x $0.00 $1.93K $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow